4.4 Article

Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum

Journal

ANTI-CANCER DRUGS
Volume 17, Issue 7, Pages 733-751

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.cad.0000217429.67455.18

Keywords

amplified in breast cancer 1; Akt; cis-platinum; DEAD/H box helicase 21; glioma; hepatocyte growth factor; nuclear factor-kappa B; polycystic kidney disease 1; scatter factor; U373MG

Funding

  1. NCI NIH HHS [R01-CA82599] Funding Source: Medline
  2. NIEHS NIH HHS [R01-ES09169] Funding Source: Medline
  3. NINDS NIH HHS [R01-NS43987] Funding Source: Medline

Ask authors/readers for more resources

Scatter factor (hepatocyte growth factor) and its receptor c-Met are increasingly expressed during progression from low-grade to high-grade gliomas. Scatter factor/c-Met signaling induces glioma cell motility, invasion, angiogenesis and resistance to DNA-damaging agents. The latter is relevant to the understanding of the resistance of human gliomas to chemotherapy and radiotherapy. The goal of this study was to identify a set of genes that may contribute to scatter factor-mediated protection of U373MG cells against cis-platinum, a DNA cross-linking agent We used DNA microarray assays, confirmatory semiquantitative reverse transcription-polymerase chain reaction analysis and functional assays to identify genes involved in the scatter factor-induced resistance of U373MG to cis-platinum. We identified a group of genes that are overexpressed in cells treated with scatter factor plus cis-platinum relative to cells treated with cis-platinum alone and confirmed some of these gene expression alterations by reverse transcription-polymerase chain reaction. Inhibiting the expression of three of these genes - polycystic kidney disease 1, amplified in breast cancer 1 and DEAD/H box helicase 21 - using small interfering RNAs reduced survival of cis-platinum-treated cells and partially reversed the scatter factor protection against cis-platinum. Dominant-negative Akt and IKB super-repressor expression vectors inhibited the scatter factor protection, and abrogated the ability of scatter factor to alter the expression of DEAD/H box helicase 21 and polycystin (PKD1) within the context of cis-platinum exposure. The Akt and nuclear factor-kappa B inhibitors had no effect on amplified in breast cancer 1 expression. These studies implicate DEAD/H box helicase 21, polycystin (PKD1) and amplified in breast cancer I as novel transcription-dependent regulators of scatter factor-mediated glioma cell protection against cytotoxic death, and identify other potential regulators for future study.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available